Frequency of BKC-1-producing Klebsiella species isolates

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 8, 2016, Pages 5044-5046

  Martins, Willames M B S ^a   Nicoletti, Adriana G ^a   Santos, Silvia R ^b   Sampaio, Jorge L M ^b,c   Gales, Ana C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Fleury   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BKC 1 PROTEIN; CARBAPENEMASE; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OUTER MEMBRANE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; ESCHERICHIA COLI; GENE MUTATION; GENETIC CODE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; KLEBSIELLA; METABOLISM; MICROBIAL SENSITIVITY TEST; MUTATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MUTATION; PLASMIDS;

EID: 84979518930     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00470-16     Document Type: Article

References (8)

1. Pitout JDD, Nordmann P, Poirel L. 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873-5884. http://dx.doi.org/10.1128/AAC.01019-15.
2. Nicoletti AG, Marcondes MFM, Martins WMBS, Almeida LGP, Nicolás MF, Vasconcelos ATR, Oliveira V, Gales AC. 2015. Characterization of BKC-1 class A carbapenemase from Klebsiella pneumoniae clinical isolates in Brazil. Antimicrob Agents Chemother 59:5159-5164. http://dx.doi.org/10.1128/AAC.00158-15.
3. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178-4182. http://dx.doi.org/10.1128/JCM.43.8.4178-4182.2005.
4. Clinical and Laboratory Standards Institute. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - 10th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. CLSI document M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Türkoglu S, Nordmann P. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70:75-80. http://dx.doi.org/10.1093/jac/dku323.
7. Kieser T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36. http://dx.doi.org/10.1016/0147-619X(84)90063-5.
8. Martins WMBS, Cordeiro-Moura JR, Ramos AC, Fehlberg LC, Nicoletti AG, Gales AC. 2016. Comparison of phenotypic tests for detecting BKC-1-producing Enterobacteriaceae isolates. Diagn Microbiol Infect Dis 84: 246-248. http://dx.doi.org/10.1016/j.diagmicrobio.2015.11.021.